Vensica
vensica.com
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$19M
1 round on record
Latest round
$19M
Venture round · Feb 2022 · 4 yr ago
Backers
1
The Trendlines Group
The money's age
Long since its last round
56 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Feb 7, 2022
Raised a round Venture round $19M · PRNewswire
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Feb 2022 | $19M | — | PRNewswire |
Backed byfrom the funds' portfolios and accelerator catalogs
The Trendlines Group News
Vensica Medical Ltd. announced that it has received $0.9 million in funding from The Trendlines Group Ltd., Librae Holdings Limited
Read more
Report
Trendlines portfolio company Vensica Medical's needle-free bladder therapy progress into Phase two of clinical trial
Vensica Medical is supported by numerous investors and strategic partners, including Merz Pharma, Laborie, Israel Biotech Fund and Trendlines.
Read more
Report
Vensica Medical Receives FDA IND Clearance to Initiate Phase 2 Study of ViXe, Its Needle-Free Xeomin Delivery System for Overactive Bladder
Read more
Report
Vensica Medical: Urology Therapeutics Company Raises $11 Million
Vensica Medical - a pioneering urology therapeutics company, announced the closing of an $11 million funding round. This funding was led by Israel Biotech Fund (IBF), along with key strategic partners Merz (a global player in neurotoxins) and Laborie (a p
Read more
Report
- Company Announcement - FT.com
The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting rights, and directors and dealings.
Read more
Report
Vensica Medical Secures $11M in Funding to Support Phase 2 Trials for Overactive Bladder Treatment
Read more
Report
Vensica Closes $19 Million Round with Investment from Strategic Partner Merz
/PRNewswire/ -- Vensica Therapeutics ("Vensica"), a clinical stage biopharmaceutical company, has closed a $19 million investment round. Vensica executed a...
Read more
Report
Vensica Therapeutics Closes $16 Million Investment Round
/PRNewswire/ -- Vensica Therapeutics ("Vensica"), a clinical stage biopharmaceutical company, announced that it has closed an investment round of $16 million....
Read more
Report
Financials
Total raised
$19M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2022 | $19M | Details |